Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study
2012 · British Journal of Cancer · 109 citations
https://doi.org/10.1038/bjc.2012.348
M
Massimo Breccia
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.0K
Papers
17.3K
Citations
60
h-index
372
i10-index
Massimo Breccia is an academic researcher from University of L'Aquila. The author has contributed to research in topics: Chronic Myeloid Leukemia Treatments & Chronic Lymphocytic Leukemia Research & Acute Myeloid Leukemia Research. The author has an h-index of 60, co-authored 888 publications.
ORCID: 0000-0003-1163-6162Papers by this author
worksDifferences among young adults, adults and elderly chronic myeloid leukemia patients
2014 · Annals of Oncology · 98 citations
https://doi.org/10.1093/annonc/mdu490
Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study
2015 · The Lancet Oncology · 84 citations
https://doi.org/10.1016/s1470-2045(15)00206-5
NF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia
2010 · Expert Opinion on Therapeutic Targets · 49 citations
https://doi.org/10.1517/14728222.2010.522570
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results
2023 · Leukemia · 43 citations
https://doi.org/10.1038/s41375-023-01860-w
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results
2024 · Leukemia · 42 citations
https://doi.org/10.1038/s41375-024-02278-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat